Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on May 17, 2004

Circulation. 2004
Published online before print May 17, 2004, doi: 10.1161/01.CIR.0000129764.84596.EB
A more recent version of this article appeared on June 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/21/2550    most recent
01.CIR.0000129764.84596.EBv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, J. F.
Right arrow Articles by Dreyer, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, J. F.
Right arrow Articles by Dreyer, W. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Congestive
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery

Submitted on October 29, 2003
Revised on February 5, 2004
Accepted on February 17, 2004

Arginine Vasopressin Levels Are Elevated and Correlate With Functional Status in Infants and Children With Congestive Heart Failure

Jack F. Price MD, Jeffrey A. Towbin MD, Susan W. Denfield MD, Sarah Clunie BSN, RN, E. O. Smith PhD, Colin J. McMahon MB, MRCPI, Branislav Radovancevic MD, and William J. Dreyer MD*

From the Departments of Pediatrics (Cardiology) (J.F.P., J.A.T., S.W.D., S.C., C.J.M., W.J.D.), Molecular and Human Genetics (J.A.T.), and Biostatistics (E.O.S.), Baylor College of Medicine, Texas Children’s Hospital, and Department of Surgery (B.R.), Texas Heart Institute, Houston, Tex.

* To whom correspondence should be addressed. E-mail: wdreyer{at}bcm.tmc.edu.

Background--Arginine vasopressin (AVP) is a vasoactive hormone that acts on the kidney to conserve solute-free water and produces a potent vasoconstrictive effect during hypovolemic states. AVP levels are elevated in adults with congestive heart failure (CHF), and early clinical trials using AVP antagonists are being conducted. The purpose of this study was to determine if AVP levels (1) are elevated in children with CHF attributable to left ventricular dysfunction or pulmonary overcirculation attributable to large left-to-right shunts and (2) can predict functional clinical status.

Methods and Results--AVP levels were measured in patients with dilated cardiomyopathy (DCM) and CHF and in patients with large left-to-right intracardiac shunts. Each patient with DCM (ejection fraction percent <40%) was classified as NYHA functional class I through IV when the AVP level was drawn. Serum sodium was measured, serum osmolality was calculated, and echocardiograms and chest radiographs were performed on all study patients. AVP levels were also measured in age-matched controls. Mean AVP level in children with DCM (n=27) was 10.3 pg/mL (±12.8) versus 3.7 pg/mL (±2.4) in controls (n=15) (P<0.01). Mean AVP level in children with left-to-right shunts (n=14) was 13.9 pg/mL (±17.3) versus 3.5 pg/mL (±1.3) in controls (n=8) (P<0.04). In patients with DCM, AVP levels correlated directly with NYHA functional class (r2=0.73, P<0.001).

Conclusions--Arginine vasopressin levels are elevated in infants and children with CHF attributable to left ventricular dysfunction and in infants with large left-to-right intracardiac shunts. Furthermore, there is a direct relationship between AVP level and the severity of heart failure in patients with DCM.


Key words: pediatrics • heart failure • hormones